37
01/01/2024
31/12/2024
2024-12-31
false
false
false
false
true
false
false
false
false
false
true
false
false
true
false
false
false
false
true
true
false
No description of principal activities is disclosed
2024-01-01
Sage Accounts Production 24.0 - FRS102_2024
xbrli:pure
xbrli:shares
iso4217:GBP
NI616081
2024-01-01
2024-12-31
NI616081
2024-12-31
NI616081
2023-12-31
NI616081
2023-01-01
2023-12-31
NI616081
2023-12-31
NI616081
2022-12-31
NI616081
core:Subsidiary1
2024-01-01
2024-12-31
NI616081
core:Subsidiary2
2024-01-01
2024-12-31
NI616081
core:Subsidiary3
2024-01-01
2024-12-31
NI616081
core:Subsidiary5
2024-01-01
2024-12-31
NI616081
bus:RegisteredOffice
2024-01-01
2024-12-31
NI616081
bus:OrdinaryShareClass1
2024-01-01
2024-12-31
NI616081
bus:LeadAgentIfApplicable
2024-01-01
2024-12-31
NI616081
bus:Director1
2024-01-01
2024-12-31
NI616081
bus:Director3
2024-01-01
2024-12-31
NI616081
bus:Director4
2024-01-01
2024-12-31
NI616081
bus:Director5
2024-01-01
2024-12-31
NI616081
bus:Director6
2024-01-01
2024-12-31
NI616081
bus:Director7
2024-01-01
2024-12-31
NI616081
bus:CompanySecretary1
2024-01-01
2024-12-31
NI616081
core:WithinOneYear
2024-12-31
NI616081
core:WithinOneYear
2023-12-31
NI616081
core:FurnitureFittingsToolsEquipment
2023-12-31
NI616081
core:FurnitureFittingsToolsEquipment
2024-12-31
NI616081
core:ExternallyAcquiredIntangibleAssets
2024-01-01
2024-12-31
NI616081
core:FurnitureFittingsToolsEquipment
2024-01-01
2024-12-31
NI616081
core:AfterOneYear
2023-12-31
NI616081
core:RetainedEarningsAccumulatedLosses
2023-01-01
2023-12-31
NI616081
core:RetainedEarningsAccumulatedLosses
2024-01-01
2024-12-31
NI616081
core:ShareCapital
2024-12-31
NI616081
core:ShareCapital
2023-12-31
NI616081
core:SharePremium
2024-12-31
NI616081
core:SharePremium
2023-12-31
NI616081
core:RetainedEarningsAccumulatedLosses
2024-12-31
NI616081
core:RetainedEarningsAccumulatedLosses
2023-12-31
NI616081
core:ShareCapital
2022-12-31
NI616081
core:SharePremium
2022-12-31
NI616081
core:RetainedEarningsAccumulatedLosses
2022-12-31
NI616081
core:PreviouslyStatedAmount
core:ShareCapital
2024-12-31
NI616081
bus:OrdinaryShareClass1
core:ShareCapital
2024-12-31
NI616081
bus:OrdinaryShareClass1
core:ShareCapital
2023-12-31
NI616081
core:BetweenOneFiveYears
2024-12-31
NI616081
core:BetweenOneFiveYears
2023-12-31
NI616081
core:UKTax
2023-01-01
2023-12-31
NI616081
core:CostValuation
core:Non-currentFinancialInstruments
2023-12-31
NI616081
core:DisposalsRepaymentsInvestments
core:Non-currentFinancialInstruments
2024-12-31
NI616081
core:CostValuation
core:Non-currentFinancialInstruments
2024-12-31
NI616081
core:Non-currentFinancialInstruments
2024-12-31
NI616081
core:Non-currentFinancialInstruments
2023-12-31
NI616081
core:FurnitureFittingsToolsEquipment
2023-12-31
NI616081
bus:Director1
2023-12-31
NI616081
bus:Director1
2024-12-31
NI616081
bus:Director1
2023-12-31
NI616081
bus:Director1
2023-01-01
2023-12-31
NI616081
bus:MediumEntities
2024-01-01
2024-12-31
NI616081
bus:Audited
2024-01-01
2024-12-31
NI616081
bus:Medium-sizedCompaniesRegimeForAccounts
2024-01-01
2024-12-31
NI616081
bus:PrivateLimitedCompanyLtd
2024-01-01
2024-12-31
NI616081
bus:FullAccounts
2024-01-01
2024-12-31
NI616081
1
2023-01-01
2023-12-31
NI616081
core:RetainedEarningsAccumulatedLosses
1
2023-01-01
2023-12-31
NI616081
core:ComputerSoftware
2023-12-31
NI616081
core:ComputerSoftware
core:ExternallyAcquiredIntangibleAssets
2024-01-01
2024-12-31
NI616081
core:ComputerSoftware
2024-12-31
NI616081
core:ComputerSoftware
2024-01-01
2024-12-31
NI616081
core:ComputerEquipment
2023-12-31
NI616081
core:ComputerEquipment
2024-01-01
2024-12-31
NI616081
core:ComputerEquipment
2024-12-31
NI616081
core:Associate1
2024-01-01
2024-12-31
NI616081
core:AllAssociates
2024-01-01
2024-12-31
Company registration number:
NI616081
Connected Health Limited
Financial statements
31 December 2024
Connected Health Limited
Contents
Directors and other information
Strategic report
Directors report
Independent auditor's report to the members
Statement of comprehensive income
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Connected Health Limited
Directors and other information
|
|
|
|
|
Directors |
Douglas Adams |
|
|
|
Robin Horner |
(Resigned 20 November 2024) |
|
|
Kevin Lagan |
(Resigned 20 November 2024) |
|
|
Brian O'Connor |
(Resigned 20 November 2024) |
|
|
Robert Notley |
(Resigned 20 November 2024) |
|
|
Ryan Williams |
|
|
|
|
|
|
|
|
|
|
Secretary |
Julie Cordner |
|
|
|
|
|
|
|
|
|
|
Company number |
NI616081 |
|
|
|
|
|
|
|
|
|
|
Registered office |
3b Boucher Business Studios |
|
|
|
Glenmachan Place |
|
|
|
Belfast |
|
|
|
BT12 6QH |
|
|
|
|
|
|
|
|
|
|
Auditor |
Hill Vellacott |
|
|
|
Chamber of Commerce House |
|
|
|
22 Great Victoria Street |
|
|
|
Belfast |
|
|
|
BT2 7BA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bankers |
Ulster Bank |
|
|
11 - 16 Donegall Square East |
|
|
Belfast |
|
|
BT1 5UB |
|
|
|
Connected Health Limited
Strategic report
Year ended 31 December 2024
Business review and position
The principal activity of the company is the provision of domiciliary health care services
The directors are satisfied with the company's performance.
The company operates in a very competitive marketplace and the directors have taken steps to ensure that the company will maintain its competitive strengths and are confident of future results.
Given the nature of the company's activities, the directors are of the opinion that the use of key performance indicators is not necessary for an understanding of the development, performance or position of the company.
Financial risk management objectives and policies
The company has exposure to liquidity risk and customer credit exposure. To a lesser extent the company is exposed to interest rate risk.
The objective of the company in managing liquidity risk is to ensure that it can meet its financial obligations as and when they fall due. The company expects to meet its financial obligations through operating cash flows. In the event that the operating cash flows would not cover all the financial obligations the company will seek additional credit facilities. Given the maturity of the bank loans, the company is in position to meet its commitments and obligations as they come due.
The company borrows from its bankers using either overdrafts or term loans whose tenure depends on the nature of the asset and management's view of the future direction of interest rate.
This report was approved by the board of directors on 22 July 2025 and signed on behalf of the board by:
Douglas Adams
Director
Ryan Williams
Director
Connected Health Limited
Directors report
Year ended 31 December 2024
The directors present their report and the financial statements of the company for the year ended 31 December 2024.
Directors
The directors who served the company during the year were as follows:
|
|
|
|
|
|
Douglas Adams |
|
|
|
|
|
Robin Horner |
|
|
|
(Resigned 20 November 2024) |
|
Kevin Lagan |
|
|
|
(Resigned 20 November 2024) |
|
Brian O'Connor |
|
|
|
(Resigned 20 November 2024) |
|
Robert Notley |
|
|
|
(Resigned 20 November 2024) |
|
Ryan Williams |
|
|
|
|
|
|
|
|
|
Dividends
The directors do not recommend the payment of a dividend.
Future developments
The directors will continue to develop the business and will seek to take advantage of oppurtunities that arise in the future.
Financial instruments
Details of the financial instruments are provided in the strategic report on page 2.
Directors responsibilities statement
The directors are responsible for preparing the strategic report, directors report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
-
select suitable accounting policies and then apply them consistently;
-
make judgments and accounting estimates that are reasonable and prudent; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Auditor
Each of the persons who is a director at the date of approval of this report confirms that:
-
so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.
The auditor is deemed to have been re-appointed in accordance with section 487 of the Companies Act 2006.
This report was approved by the board of directors on
22 July 2025
and signed on behalf of the board by:
Douglas Adams
Ryan Williams
Director
Director
Independent auditor's report to the members of
Connected Health Limited
Year ended 31 December 2024
Opinion
We have audited the financial statements of Connected Health Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements: - give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and - have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the strategic report and the directors' report has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and the returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Our approach was as follows: We obtained an understanding of the legal and regulatory frameworks that are applicable to the entity and determined that the most significant are those that relate to the Companies Act 2006 and compliance with FRS102; and we assessed the risks of material misstatement in respect of fraud with the consideration of the company's own assessment of the risks that irregularities may occur either because of fraud or error; the results of our enquiries of management about their own identification and assessment of the risks of irregularities; any matters we identified having obtained and reviewed the company's documentation of their policies and procedures relating to identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance; detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud; the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations; and the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud. Based on the results of our risk assessment we designed our audit procedures to identify non-compliance with such laws and regulations identified above, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the areas in which management is required to exercise significant judgment, such as disclosure of adjusting items. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override; we also obtained an understanding of the legal and regulatory framework that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included UK Companies Act and tax legislation; and in addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company's ability to operate or to avoid a material penalty. These included data protection, employment and health and safety regulations. Audit procedures designed to respond to the risks of fraud: We considered the risk of fraud through management override and, in response, we incorporated testing of manual journal entries into our audit approach. We considered the risk of fraud through transactions outside the normal course of transactions by noting anything that was unusual in nature or size and enquired about such transaction to gain an understanding of their nature; based on the results of our risk assessment we designed our audit procedures to identify and to address material misstatements in relation to fraud and other irregularities; extent of audit procedures; and we evaluated the selection and application of accounting policies by the company, particularly those related to subjective measurements and complex transactions, that may be indicative of fraudulent financial reporting. A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditors report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Eoin McMullan
(Senior Statutory Auditor)
For and on behalf of
Hill Vellacott
Chartered Accountants
Chamber of Commerce House
22 Great Victoria Street
Belfast
BT2 7BA
22 July 2025
Connected Health Limited
Statement of comprehensive income
Year ended 31 December 2024
|
|
|
|
2024 |
|
2023 |
|
|
|
|
Note |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turnover |
|
4 |
|
29,133 |
|
397,900 |
|
|
|
Cost of sales |
|
|
|
(
58,400) |
|
(
371,465) |
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Gross (loss)/profit |
|
|
|
(
29,267) |
|
26,435 |
|
|
|
|
|
|
|
|
|
|
|
|
Administrative expenses |
|
|
|
(
2,884,025) |
|
(
2,538,968) |
|
|
|
Other operating income |
|
5 |
|
116,422 |
|
73,006 |
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Operating loss |
|
6 |
|
(
2,796,870) |
|
(
2,439,527) |
|
|
|
|
|
|
|
|
|
|
|
|
Other interest receivable and similar income |
|
9 |
|
(
60,793) |
|
(
132,163) |
|
|
|
Amounts written off investments |
|
10 |
|
(
200,000) |
|
- |
|
|
|
Interest payable and similar expenses |
|
11 |
|
- |
|
(
7,840) |
|
|
|
Loss before taxation |
|
|
|
(
3,057,663) |
|
(
2,579,530) |
|
|
|
|
|
|
|
|
|
|
|
|
Tax on loss |
|
12 |
|
- |
|
(
903) |
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Loss for the financial year |
|
|
|
(
3,057,663) |
|
(
2,580,433) |
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Other comprehensive income |
|
|
|
- |
|
34,500 |
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Total comprehensive income for the year |
|
|
|
(
3,057,663) |
|
(
2,545,933) |
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
All the activities of the company are from continuing operations.
Connected Health Limited
Statement of financial position
31 December 2024
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
Note |
£ |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
13 |
257,621 |
|
|
|
221,887 |
|
|
|
Tangible assets |
|
14 |
91,209 |
|
|
|
141,755 |
|
|
|
Investments |
|
15 |
5,986,723 |
|
|
|
6,186,723 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
6,335,553 |
|
|
|
6,550,365 |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
Debtors |
|
16 |
138,582 |
|
|
|
272,144 |
|
|
|
Cash at bank and in hand |
|
|
189,919 |
|
|
|
71,012 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
328,501 |
|
|
|
343,156 |
|
|
|
Creditors: amounts falling due |
|
|
|
|
|
|
|
|
|
|
within one year |
|
17 |
(
20,035,820) |
|
|
|
(
16,287,554) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
Net current liabilities |
|
|
|
|
(
19,707,319) |
|
|
|
(
15,944,398) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Total assets less current liabilities |
|
|
|
|
(
13,371,766) |
|
|
|
(
9,394,033) |
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due |
|
|
|
|
|
|
|
|
|
|
after more than one year |
|
18 |
|
|
- |
|
|
|
(
920,070) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Net liabilities |
|
|
|
|
(
13,371,766) |
|
|
|
(
10,314,103) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
|
|
|
Called up share capital |
|
21 |
|
|
1,273 |
|
|
|
1,273 |
|
Share premium account |
|
22 |
|
|
138,364 |
|
|
|
138,364 |
|
Profit and loss account |
|
22 |
|
|
(
13,511,403) |
|
|
|
(
10,453,740) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Shareholders deficit |
|
|
|
|
(
13,371,766) |
|
|
|
(
10,314,103) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
These financial statements were approved by the
board of directors
and authorised for issue on
22 July 2025
, and are signed on behalf of the board by:
Douglas Adams
Ryan Williams
Director
Director
Company registration number:
NI616081
Connected Health Limited
Statement of changes in equity
Year ended 31 December 2024
|
|
Called up share capital |
Share premium account |
|
Profit and loss account |
Total |
|
|
|
|
|
|
£ |
£ |
|
£ |
£ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2023 |
|
1,273 |
138,364 |
|
(
7,907,807) |
(
7,768,170) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for the year |
|
|
|
|
(
2,580,433) |
(
2,580,433) |
|
|
|
|
|
Other comprehensive income for the year: |
|
|
|
|
|
|
|
|
|
|
|
User defined other comprehensive income movement 1 |
|
- |
- |
|
34,500 |
34,500 |
|
|
|
|
|
|
_______ |
_______ |
|
_______ |
_______ |
|
|
|
|
|
Total comprehensive income for the year |
|
- |
- |
|
(
2,545,933) |
(
2,545,933) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
_______ |
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2023 and 1 January 2024 |
|
1,273 |
138,364 |
|
(
10,453,740) |
(
10,314,103) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for the year |
|
|
|
|
(
3,057,663) |
(
3,057,663) |
|
|
|
|
|
|
_______ |
_______ |
|
_______ |
_______ |
|
|
|
|
|
Total comprehensive income for the year |
|
- |
- |
|
(
3,057,663) |
(
3,057,663) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
_______ |
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2024 |
|
1,273 |
138,364 |
|
(
13,511,403) |
(
13,371,766) |
|
|
|
|
|
|
_______ |
_______ |
|
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Connected Health Limited
Notes to the financial statements
Year ended 31 December 2024
1.
General information
The company is a private company limited by shares, registered in Nothern Ireland. The address of the registered office is Connected Health Limited, 3b Boucher Business Studios, Glenmachan Place, Belfast, BT12 6QH.
2.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the exemption from preparing consolidated financial statements contained in Section 400 of the Companies Act 2006 on the basis that it is a subsidiary undertaking and its immediate parent undertaking is established under the law of any part of the United Kingdom.
The company has not prepared a cash flow statement as this will be included in the consolidated financial statements.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Significant judgementsThere are no judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have the most significant effect on the amounts recognised in the financial statements.Key sources of estimation uncertaintyAccounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. The key assumptions and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are as follows:Impairment of trade debtors is reviewed on an ongoing basis. The company uses estimates based on historical experience and current information in determining the debts for which an impairmentt charge is required.
Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts.
When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period.
When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to profit or loss.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at a revalued amount, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4.
Turnover
Turnover arises from:
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Rendering of services |
|
29,133 |
397,900 |
|
|
|
_______ |
_______ |
|
|
|
|
|
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5.
Other operating income
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Government grant income |
|
116,302 |
61,006 |
|
Other operating income |
|
120 |
12,000 |
|
|
|
_______ |
_______ |
|
|
|
116,422 |
73,006 |
|
|
|
_______ |
_______ |
|
|
|
|
|
6.
Operating loss
Operating loss is stated after charging/(crediting):
|
|
|
|
2024 |
2023 |
|
|
|
|
£ |
£ |
|
Amortisation of intangible assets |
|
|
27,854 |
- |
|
Depreciation of tangible assets |
|
|
76,983 |
73,917 |
|
Operating lease rentals |
|
|
(
370) |
9,175 |
|
Foreign exchange differences |
|
|
3,267 |
187 |
|
Fees payable for the audit of the financial statements |
|
|
21,000 |
21,000 |
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
7.
Staff costs
The average number of persons employed by the company during the year, including the directors, amounted to:
|
|
|
2024 |
2023 |
|
Administrative staff |
|
35 |
31 |
|
Carers |
|
2 |
22 |
|
|
|
_______ |
_______ |
|
|
|
37 |
53 |
|
|
|
_______ |
_______ |
|
|
|
|
|
The aggregate payroll costs incurred during the year were:
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Wages and salaries |
|
1,519,834 |
1,413,361 |
|
Social security costs |
|
168,759 |
149,474 |
|
Other pension costs |
|
122,343 |
71,565 |
|
|
|
_______ |
_______ |
|
|
|
1,810,936 |
1,634,400 |
|
|
|
_______ |
_______ |
|
|
|
|
|
8.
Directors remuneration
The directors aggregate remuneration in respect of qualifying services was:
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Remuneration |
|
160,000 |
110,000 |
|
|
|
_______ |
_______ |
|
|
|
|
|
9.
Other interest receivable and similar income
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Loans and receivables |
|
(60,793) |
(132,163) |
|
|
|
_______ |
_______ |
|
|
|
|
|
10.
Amounts written off investments
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Impairment of investments in associates |
|
200,000 |
- |
|
|
|
_______ |
_______ |
|
|
|
|
|
11.
Interest payable and similar expenses
|
|
|
|
2024 |
2023 |
|
|
|
|
£ |
£ |
|
Other interest payable and similar expenses |
|
|
- |
7,840 |
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
12.
Tax on loss
Major components of tax expense
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Current tax: |
|
|
|
|
Adjustments in respect of previous periods |
|
- |
903 |
|
|
|
_______ |
_______ |
|
Tax on loss |
|
- |
903 |
|
|
|
_______ |
_______ |
|
|
|
|
|
Reconciliation of tax expense
The tax assessed on the loss for the year is higher than (2023: higher than) the
standard rate of corporation tax in the UK
of
25.00
% (2023: 25.00%).
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Loss before taxation |
|
(
3,057,663) |
(
2,579,530) |
|
|
|
_______ |
_______ |
|
|
|
|
|
|
Loss multiplied by rate of tax |
|
(
764,416) |
(
644,883) |
|
Adjustments in respect of prior periods |
|
- |
903 |
|
Effect of expenses not deductible for tax purposes |
|
63,422 |
- |
|
Effect of capital allowances and depreciation |
|
(
58,732) |
- |
|
Utilisation of tax losses |
|
759,726 |
644,883 |
|
|
|
_______ |
_______ |
|
Tax on loss |
|
- |
903 |
|
|
|
_______ |
_______ |
|
|
|
|
|
13.
Intangible assets
|
|
Software development |
Total |
|
|
|
|
|
|
£ |
£ |
|
|
|
|
|
Cost |
|
|
|
|
|
|
|
At 1 January 2024 |
221,887 |
221,887 |
|
|
|
|
|
Additions |
63,588 |
63,588 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2024 |
285,475 |
285,475 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
Amortisation |
|
|
|
|
|
|
|
At 1 January 2024 |
- |
- |
|
|
|
|
|
Charge for the year |
27,854 |
27,854 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2024 |
27,854 |
27,854 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
At 31 December 2024 |
257,621 |
257,621 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2023 |
221,887 |
221,887 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
14.
Tangible assets
|
|
Fixtures, fittings and equipment |
Computer equipment |
Total |
|
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
|
Cost |
|
|
|
|
|
|
|
|
At 1 January 2024 |
52,619 |
268,239 |
320,858 |
|
|
|
|
|
Additions |
250 |
26,187 |
26,437 |
|
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
At 31 December 2024 |
52,869 |
294,426 |
347,295 |
|
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
Depreciation |
|
|
|
|
|
|
|
|
At 1 January 2024 |
25,817 |
153,286 |
179,103 |
|
|
|
|
|
Charge for the year |
12,591 |
64,392 |
76,983 |
|
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
At 31 December 2024 |
38,408 |
217,678 |
256,086 |
|
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
|
At 31 December 2024 |
14,461 |
76,748 |
91,209 |
|
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
At 31 December 2023 |
26,802 |
114,953 |
141,755 |
|
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
15.
Investments
|
|
Shares in group undertakings |
Total |
|
|
|
|
|
|
£ |
£ |
|
|
|
|
|
Cost |
|
|
|
|
|
|
|
At 1 January 2024 |
6,186,723 |
6,186,723 |
|
|
|
|
|
Disposals |
(
200,000) |
(
200,000) |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2024 |
5,986,723 |
5,986,723 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
Impairment |
|
|
|
|
|
|
|
At 1 January 2024 and 31 December 2024 |
- |
- |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
At 31 December 2024 |
5,986,723 |
5,986,723 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
At 31 December 2023 |
6,186,723 |
6,186,723 |
|
|
|
|
|
|
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments in group undertakings |
|
|
|
|
|
|
|
Registered office |
Class of share |
Percentage of shares held |
|
Subsidiary undertakings |
|
|
|
|
|
Connected Health Domiciliary Care Limited |
|
3B Boucher Business Studios, Glenmachan Place, Belfast. |
Ordinary |
100 |
|
|
|
|
|
|
|
Home Care Plus Limited |
|
Unit 3, First Floor BLock 3, Belgard Road, Tallaght, Dublin 4, DUBLIN, Ireland. |
Ordinary |
100 |
|
|
|
|
|
|
|
IBBSOL Limited |
|
Unit 3, First Floor BLock 3, Belgard Road, Tallaght, Dublin 4, DUBLIN, Ireland. |
Ordinary |
100 |
|
|
|
|
|
|
|
Connected Health (Care NI) Limited |
|
|
Ordinary |
100 |
|
|
|
|
|
|
16.
Debtors
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Trade debtors |
|
7,691 |
16,419 |
|
Prepayments and accrued income |
|
89,274 |
50,127 |
|
Other debtors |
|
41,617 |
205,598 |
|
|
|
_______ |
_______ |
|
|
|
138,582 |
272,144 |
|
|
|
_______ |
_______ |
|
|
|
|
|
17.
Creditors: amounts falling due within one year
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Bank loans and overdrafts |
|
- |
537,226 |
|
Trade creditors |
|
48,294 |
139,798 |
|
Amounts owed to group undertakings |
|
19,353,330 |
15,490,917 |
|
Amounts owed to parent company |
|
438,348 |
- |
|
Accruals and deferred income |
|
81,454 |
49,788 |
|
Corporation tax |
|
1,615 |
- |
|
Social security and other taxes |
|
54,971 |
53,343 |
|
Other creditors |
|
57,808 |
16,482 |
|
|
|
_______ |
_______ |
|
|
|
20,035,820 |
16,287,554 |
|
|
|
_______ |
_______ |
|
|
|
|
|
The bank have fixed and floating charge over the assets of the company, there are cross guarantees with all subsiduary companies.
18.
Creditors: amounts falling due after more than one year
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Bank loans and overdrafts |
|
- |
920,070 |
|
|
|
_______ |
_______ |
|
|
|
|
|
The bank have fixed and floating charge over the assets of the company, there are cross gaurentees with all subsiduary companies.
19.
Employee benefits
The amount recognised in profit or loss in relation to defined contribution plans was £
122,343
(2023: £
71,565
).
20.
Government grants
The amounts recognised in the financial statements for government grants are as follows:
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Recognised in other operating income: |
|
|
|
|
Government grants recognised directly in income |
|
116,302 |
61,006 |
|
|
|
_______ |
_______ |
|
|
|
|
|
21.
Called up share capital
Issued, called up and fully paid
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
No |
|
£ |
|
No |
|
£ |
|
Ordinary shares of £
0.25 each |
|
5,090 |
|
1,273 |
|
5,090 |
|
1,273 |
|
|
|
_______ |
|
_______ |
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
22.
Reserves
Profit and loss account:This reserve records retained earnings and accumulated losses.
23.
Operating leases
The company as lessee
The total future minimum lease payments under non-cancellable operating leases are as follows:
|
|
|
|
£ |
£ |
|
|
|
| Not later than 1 year |
152,312 |
112,321 |
| Later than 1 year and not later than 5 years |
420,649 |
72,390 |
|
_______ |
_______ |
|
572,961 |
184,711 |
|
_______ |
_______ |
|
|
|
24.
Limitation of auditors liability
The company has entered into a liability limitaion agreement with the company's auditor which was approved on 03 March 2025. The principal terms of the agreement are that the auditor's liability is limited to a multiple of the audit fee issued and paid for the year, but the mulitple cannot be lessthan such amount as is fair and resonable.
25.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Douglas Adams |
14,454 |
(
9,668) |
4,786 |
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Douglas Adams |
- |
14,454 |
14,454 |
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
26.
Related party transactions
Nightingale Bidco Limited owns 100% of the share capital of
Connected Health Limited
. At the balance sheet date the company owed £14,863,150 (2023: - £13,031,156) to Connected Health Domiciliary Care Limited.At the balance sheet date the company owed £1,969,302 (2023: - £1,785,073) to Home Care Plus Limited. At the balance sheet date the company owed £2,520,878 (2023: - £674,688) to Connected Health (Care NI) Limited.At the balance sheet date the company owed £438,348 to Nightingale Bidco Limited.
27.
Controlling party
The company is 100% controlled by Nightingale Bidco Limited.